论文信息 - A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder cancer (MIBC). - 字舞流文

A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder cancer (MIBC).

G. Sonpavde | M. Galsky | J. Gschwend | G. Steinberg | A. Necchi | M. V. D. Heijden | Shilpa Gupta | A. Elegbe | Danny Liaw | Bradley Raybold | M. Rutstein | Nathalie Garzon